News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Sustained Growth at Eden Biodesign Results in the Posting of 18 New Job Openings


10/27/2009 9:34:31 AM

Bookmark and Share

The Company’s Global Reach, Continued Strong Growth, and Significant New Contracts has Fueled Demand for an Expanded Workforce

LIVERPOOL, United Kingdom & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Eden Biodesign, a globally-integrated provider of biopharmaceutical process development, cGMP manufacturing, and consultancy services, today announced that it has posted eighteen (18) new job openings located at its Liverpool, UK state-of-the-art licensed cGMP facility.

Given the breath and depth of Eden Biodesign’s contract manufacturing and consultancy services – which have achieved global recognition in the biopharmaceutical marketplace – and the continued strong growth in Eden Biodesign’s project portfolio, the positions to be filled demand a wide range of skills in manufacturing, development and quality teams. The full list of the open positions can be viewed at: http://linux.edenbiodesign.com/join-us.html.

The creation of these positions at Eden Biodesign comes after a string of positive developments at the Company, including Eden Biodesign’s selection by Biotecnol SA to manufacture Cardiotrophin-1 for potential use in certain liver indications and Omnio Healer AB, for cGMP Production of Clinical Trial Product in Wound Healing and Anti-infection. Eden Biodesign has also entered into a range of collaborative partnerships with technology leaders such as Selexis SA and Millipore for high productivity cell line development.

“We can attribute our success to a staff of extraordinary and talented professionals at Eden Biodesign,” said Crawford Brown, PhD, chief executive officer for Eden Biodesign. “Now, we are expanding that team by drawing world-class talent of the highest caliber to support our rapidly expanding global client base.”

About Eden Biodesign

Eden Biodesign is a globally-integrated biopharmaceutical company offering consultancy, biopharmaceutical design and cGMP manufacturing services to leading biotech and pharmaceutical clients around the world. With a reputation for successfully commercializing biopharmaceutical products and processes, the Company offers expertise and guidance in multiple sectors. Eden’s world-class facilities and knowledge in process development, manufacturing, regulatory and technology transfer support ensures Eden Biodesign offers much more than a traditional CMO. Learn more at www.edenbiodesign.com.

Contacts

Propel Marketing Group John D. Wagner, 919-796-9984 jdwagner@propelmg.com


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES